rifampicin

E271800

Rifampicin is a broad-spectrum rifamycin antibiotic widely used as a first-line drug in the treatment of tuberculosis and other serious bacterial infections.

All labels observed (2)

Label Occurrences
rifampicin canonical 4
rifampin 2

How this entity was disambiguated

Statements (58)

Predicate Object
instanceOf antibiotic drug ⓘ
antitubercular agent ⓘ
broad-spectrum antibiotic ⓘ
rifamycin antibiotic ⓘ
small molecule ⓘ
adverseEffect elevated liver enzymes ⓘ
flu-like syndrome ⓘ
gastrointestinal disturbances ⓘ
hepatotoxicity ⓘ
hypersensitivity reactions ⓘ
orange-red discoloration of urine, sweat, and tears ⓘ
rash ⓘ
thrombocytopenia ⓘ
approval introduced into clinical use in the late 1960s ⓘ
belongsToDrugClass first-line antitubercular drugs ⓘ
rifamycins ⓘ
chemicalFormula C43H58N4O12 ⓘ
color reddish-brown crystalline powder ⓘ
combinationTherapy used in combination with isoniazid for tuberculosis ⓘ
used in combination with isoniazid, pyrazinamide, and ethambutol for tuberculosis ⓘ
contraindication known hypersensitivity to rifamycins ⓘ
severe hepatic impairment ⓘ
discovery developed from rifamycin B produced by Streptomyces mediterranei ⓘ
drugInteraction interacts with many antiretroviral drugs ⓘ
interacts with oral contraceptives ⓘ
interacts with warfarin ⓘ
reduces plasma concentrations of many co-administered drugs ⓘ
strong inducer of cytochrome P450 enzymes ⓘ
halfLife approximately 2–5 hours in adults ⓘ
hasATCCode J04AB02 ⓘ
hasCASNumber 13292-46-1 ⓘ
hasDrugBankID DB01045 ⓘ
hasMolarMass 822.94 g/mol ⓘ
hasPubChemCID 5381226 ⓘ
indication brucellosis ⓘ
endocarditis caused by susceptible organisms ⓘ
latent tuberculosis infection ⓘ
leprosy ⓘ
prophylaxis of Haemophilus influenzae type b infection ⓘ
prophylaxis of meningococcal meningitis ⓘ
prosthetic joint infections due to staphylococci ⓘ
serious staphylococcal infections ⓘ
tuberculosis ⓘ
mechanismOfAction inhibits DNA-dependent RNA polymerase in susceptible bacteria ⓘ
pharmacokineticProperty excreted mainly in bile and feces ⓘ
metabolized primarily in the liver ⓘ
well absorbed orally on an empty stomach ⓘ
widely distributed in body tissues and fluids ⓘ
pregnancyCategory Category C (US FDA, historical) ⓘ
resistanceMechanism mutations in rpoB gene encoding RNA polymerase beta subunit ⓘ
routeOfAdministration intravenous ⓘ
oral ⓘ
spectrumOfActivity Mycobacterium leprae ⓘ
Mycobacterium tuberculosis ⓘ
many Gram-positive bacteria ⓘ
some Gram-negative bacteria ⓘ
synonym rifampin ⓘ
target bacterial DNA-dependent RNA polymerase beta subunit ⓘ

How these facts were elicited

Referenced by (6)

Full triples — surface form annotated when it differs from this entity's canonical label.

Naegleria fowleri → treatmentOption → rifampin ⓘ
linked to: rifampicin
Pregnane X receptor → activatedBy → rifampicin ⓘ
subject linked to: pregnane X receptor
CYP2B6 → inducedBy → rifampicin ⓘ
CYP3A5 → inducedBy → rifampin ⓘ
linked to: rifampicin
Pyrazinamide → usedInCombinationWith → rifampicin ⓘ
subject linked to: pyrazinamide